Risultati della ricerca - Karl Kieburtz

Raffina i risultati
  1. 1
    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease di Karl Kieburtz

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    The relationship between uric acid levels and Huntington's disease progression

    The relationship between uric acid levels and Huntington's disease progression di Peggy Auinger, Karl Kieburtz, Michael McDermott

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    A review of disease progression models of Parkinson's disease and applications in clinical trials

    A review of disease progression models of Parkinson's disease and applications in clinical trials di Charles S. Venuto, Nicholas B. Potter, E. Ray Dorsey, Karl Kieburtz

    Pubblicazione 2016
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    The relationship between CAG repeat length and clinical progression in Huntington's disease

    The relationship between CAG repeat length and clinical progression in Huntington's disease di Bernard Ravina, Megan Romer, Radu Constantinescu, Kevin Biglan, Alicia Brocht, Karl Kieburtz, Ira Shoulson, Michael McDermott

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Levodopa and the Progression of Parkinson's Disease

    Levodopa and the Progression of Parkinson's Disease di Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony E. Lang, C. Warren Olanow, Caroline M. Tanner, Kenneth Marek

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Moving Parkinson care to the home

    Moving Parkinson care to the home di E. Ray Dorsey, Floris P. Vlaanderen, Lucien JLPG Engelen, Karl Kieburtz, William Zhu, Kevin Biglan, Marjan J. Faber, Bastiaan R. Bloem

    Pubblicazione 2016
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  7. 7
    Prevalence of dementia in rural China: impact of age, gender and education

    Prevalence of dementia in rural China: impact of age, gender and education di Dao Zhou, Ching‐Fen Wu, Haitao Qi, Jin‐Hu Fan, X. D. Sun, Peter G. Como, You‐Lin Qiao, Lu Zhang, Karl Kieburtz

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Trinucleotide repeat length and progression of illness in Huntington's disease.

    Trinucleotide repeat length and progression of illness in Huntington's disease. di Karl Kieburtz, Marcy E. MacDonald, Chiu-Yang Shih, Andrew Feigin, Kim Steinberg, Kathy Bordwell, Carol Zimmerman, Jayalakshmi Srinidhi, Jenny Sotack, James F. Gusella

    Pubblicazione 1994
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort di Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Daniel Weintraub, Brit Mollenhauer, Shirley Lasch, Caroline M. Tanner, Danna Jennings, Karl Kieburtz, Lana M. Chahine, Kenneth Marek

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial di Deborah I. Friedman, Michael McDermott, Karl Kieburtz, Mark J. Kupersmith, Ann Stoutenburg, John L. Keltner, Steven E. Feldon, Eleanor Schron, James J. Corbett, Michael Wall

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial di Michael Wall, Mark J. Kupersmith, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Michael McDermott

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss

    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss di Michael Wall, Michael McDermott, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Mark J. Kupersmith

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Results of the citalopram to enhance cognition in Huntington disease trial

    Results of the citalopram to enhance cognition in Huntington disease trial di Leigh J. Beglinger, William Adams, Douglas R. Langbehn, Jess G. Fiedorowicz, Ricardo E. Jorge, Kevin Biglan, John N. Caviness, Blair Olson, Robert G. Robinson, Karl Kieburtz, Jane S. Paulsen

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease di Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease di Rachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul Aisen, Eric Siemers, Gopalan Sethuraman, Richard C. Mohs

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease di Peter A. LeWitt, Robert A. Hauser, Donald G. Grosset, Fabrizio Stocchi, Marie Saint‐Hilaire, Aaron Ellenbogen, Mika Leinonen, Neil B. Hampson, Tia DeFeo-Fraulini, Martin I. Freed, Karl Kieburtz

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Trichloroethylene: An Invisible Cause of Parkinson’s Disease?

    Trichloroethylene: An Invisible Cause of Parkinson’s Disease? di E. Ray Dorsey, Maryam Zafar, Samantha E. Lettenberger, Meghan Pawlik, Dan Kinel, Myrthe Frissen, Ruth B. Schneider, Karl Kieburtz, Caroline M. Tanner, Briana R. De Miranda, Samuel M. Goldman, Bastiaan R. Bloem

    Pubblicazione 2023
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  18. 18
    HIV-associated cognitive impairment before and after the advent of combination therapy

    HIV-associated cognitive impairment before and after the advent of combination therapy di Ned Sacktor, Michael McDermott, Karen Marder, Giovanni Schifitto, Ola A. Selnes, Justin C. McArthur, Yaakov Stern, Steven M. Albert, Donna Palumbo, Karl Kieburtz, Joy Antonelle de Marcaida, Bruce A. Cohen, Leon G. Epstein

    Pubblicazione 2002
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study di C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia di Jeffrey Sevigny, Steven M. Albert, Michael McDermott, Justin C. McArthur, Ned Sacktor, Kathy Conant, Giovanni Schifitto, Ola A. Selnes, Yaakov Stern, Daniel McClernon, Donna Palumbo, Karl Kieburtz, Garrett Riggs, Bevin Cohen, Leon G. Epstein, Karen Marder

    Pubblicazione 2004
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: